Latest Regulatory And Legal News

Australian Clinical Labs has been hit with a class action lawsuit linked to a 2022 cyberattack on Medlab Pathology, alleging breaches of consumer law and duty of care. The company denies the claims and plans a vigorous defence.

Tamboran Resources Corporation is extending its capital raise with a partially underwritten retail entitlement offer worth up to A$27 million, following a US$163 million institutional and public offering. The proceeds will accelerate drilling and resource delineation in the Beetaloo Basin, aiming to underpin first gas sales in 2026.

Melbana Energy Limited’s March quarter report details modest crude production from the Alameda-2 well in Cuba and ongoing preparations for the Amistad-11 drilling, which remains on hold due to a joint partner’s funding default. The company holds $2 million in cash and continues to process seismic data to refine its subsurface models.

Weebit Nano Ltd (ASX: WBT) has opened a non-underwritten Share Purchase Plan (SPP) offering eligible shareholders in Australia and New Zealand the chance to buy up to A$30,000 worth of shares at A$4.05 each. The company aims to raise up to A$15 million to support the commercialisation of its Resistive RAM (ReRAM) technology.

Toro Energy and IsoEnergy have agreed to extend the deadline for their acquisition scheme to June 30, 2026, alongside a $2 million bridging loan to support Toro during the extended process. The deal remains unanimously recommended by Toro’s independent board committee, pending shareholder and court approvals.

Nova Minerals has signed a Scheme Implementation Deed to redomicile to the US, aiming for a primary NYSE listing while retaining a secondary ASX listing via CDIs. The move seeks to align corporate structure with its Alaskan operations and enhance access to US capital markets.

Yowie Group Limited reported a steep 752% increase in its half-year loss to US$4.66 million, amid governance upheaval and impaired loans to its majority shareholder. The company faces ongoing legal and regulatory challenges while pursuing a turnaround.

Telix Pharmaceuticals delivered a strong 56% revenue increase in 2025, driven by U.S. sales of Illuccix and the launch of Gozellix, while advancing its therapeutic pipeline and expanding global manufacturing capabilities. Despite a net loss, the company is investing heavily in R&D and sustainability initiatives aligned with climate-related disclosures.

MEC Resources Ltd reported a half-year loss of $431,971 amid ongoing legal challenges over key gas exploration permits, while progressing investments in clean energy and neurotechnology. The company also completed a $359K options placement, reinforcing its financial position.

humm Group Limited has posted a statutory profit after tax of $13.9 million for the half-year ended 31 December 2025, marking a 49% decline from the previous year, driven by increased credit losses and legal costs. Despite challenges, the company declared a fully franked interim dividend of 1.5 cents per share.

GreenX Metals has successfully completed a A$13.6 million placement while confirming Poland’s appeal against a Singapore court ruling, underscoring ongoing legal challenges alongside fresh capital.

Apiam Animal Health has announced a fully franked special dividend of 10 cents per share, payable before the completion of its proposed acquisition by Adamantem Capital entities. The dividend is conditional on the scheme’s effectiveness and offers shareholders potential tax benefits through franking credits.